205 related articles for article (PubMed ID: 11122027)
21. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
22. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
[TBL] [Abstract][Full Text] [Related]
23. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.
Zentner A; Rendl J; Grelle I; Dummer R; Bröcker EB; Zillikens D
Arch Dermatol Res; 1994; 286(6):355-7. PubMed ID: 7979552
[No Abstract] [Full Text] [Related]
25. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.
Engineer L; Bhol K; Kumari S; Razzaque Ahmed A
Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840
[TBL] [Abstract][Full Text] [Related]
26. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
28. The localization of the bullous pemphigoid and cicatricial pemphigoid antigens: direct and indirect immunofluorescence of suction blisters.
Venning VA; Allen J; Millard PR; Wojnarowska F
Br J Dermatol; 1989 Sep; 121(3):305-15. PubMed ID: 2679855
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects.
Schmidt E; Ambach A; Bastian B; Bröcker EB; Zillikens D
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):310-2. PubMed ID: 8642104
[No Abstract] [Full Text] [Related]
30. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid.
Tedeschi A; Marzano AV; Lorini M; Balice Y; Cugno M
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):813-7. PubMed ID: 24650303
[TBL] [Abstract][Full Text] [Related]
31. Complement-independent blistering mechanisms in bullous pemphigoid.
Iwata H; Ujiie H
Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
[TBL] [Abstract][Full Text] [Related]
32. Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils.
Varigos GA; Morstyn G; Vadas MA
Clin Exp Immunol; 1982 Dec; 50(3):555-62. PubMed ID: 6762270
[TBL] [Abstract][Full Text] [Related]
33. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
Teraki Y; Hotta T; Shiohara T
J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
35. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.
Le Jan S; Plée J; Vallerand D; Dupont A; Delanez E; Durlach A; Jackson PL; Edwin Blalock J; Bernard P; Antonicelli F
J Invest Dermatol; 2014 Dec; 134(12):2908-2917. PubMed ID: 24945093
[TBL] [Abstract][Full Text] [Related]
36. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.
Kowalski EH; Kneibner D; Kridin K; Amber KT
Autoimmun Rev; 2019 May; 18(5):526-534. PubMed ID: 30844553
[TBL] [Abstract][Full Text] [Related]
37. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
[TBL] [Abstract][Full Text] [Related]
38. Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid.
Shrikhande M; Hunziker T; Braathen LR; Pichler WJ; Dahinden CA; Yawalkar N
Acta Derm Venereol; 2000; 80(4):277-80. PubMed ID: 11028861
[TBL] [Abstract][Full Text] [Related]
39. IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid.
Le Jan S; Muller C; Plee J; Durlach A; Bernard P; Antonicelli F
Front Immunol; 2019; 10():1972. PubMed ID: 31507596
[TBL] [Abstract][Full Text] [Related]
40. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
